FilingReader Intelligence

Piramal Pharma declares dividend, makes key appointments

July 30, 2025 at 03:59 PM UTCBy FilingReader AI

Piramal Pharma Limited declared a final dividend of ₹0.14 per equity share at its annual general meeting.

The company reappointed Nandini Piramal as a director, along with Amit Jain as a non-executive, non-independent director and Jairaj Purandare as an independent director.

The meeting also approved the issue of non-convertible debentures on a private placement basis.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:PPLPHARMABombay Stock Exchange

News Alerts

Get instant email alerts when PIRAMAL PHARMA publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →